Abbott’s Portico transcatheter aortic valve reduces severe aortic stenosis
Patients who received a Portico aortic heart valve had low rates of stroke, death and valve leak; and improved quality of life
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Our research aims to develop low-cost efficient anti-cancer therapeutic options: Dr P Gopinath
IIT Roorkee Professor Dr P Gopinath discusses about developing an economical and green way to detect and kill cancer cells and how…
Changes during aging in elderly persons
Dr Samir Mashelkar, Consultant-Life Science, Pharma,Biotech, discusses the damage caused by free radicals and how several heart…
Plasticell wins military contract to develop regenerative medicines for the battlefield
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer
Moderate ‘bad cholesterol’ levels tied to early death for healthy people
Researchers examined data on 36,375 adults with no history of heart disease or diabetes and a low 10-year risk for events like…
Staying fit might cut glaucoma risk: Study
The study was not designed to determine whether or how exercise or physical fitness may directly influence glaucoma risk
Earlier onset of type 1 diabetes linked to greater heart risk, shorter life
27,195 individuals aged 18 years and older in the Swedish National Diabetes Register who had been diagnosed with type 1 diabetes…
Aptamers in cancer therapeutics
Dr Harleen Kaur,Senior Scientist, AstraZeneca USA, through her research paper, talks about collaborative approaches which can…
Genome editing using CRISPR-Cas9 system shows tremendous promise
Research published in Nature Medicine describes collaborative effort to reduce off-target CRISPR-Cas9 genome editing, removing…
Eisai/Biogen to advance Alzheimer’s drug, provide fresh hope
According to Eisai, the company had already contacted various regulators and plans to pursue accelerated approvals
US FDA approves Krintafel for radical cure of P. vivax malaria
First single-dose medicine to prevent the relapse of P. vivax malaria marks a major contribution towards malaria eradication…
Verseon presents anticancer drug candidates targeting multidrug resistant cancers
Verseon’s drug candidates target cancer cells by inhibiting the protein tubulin, which leads to cell cycle arrest
Helperby Therapeutics announces phase 1 results demonstrating multiple benefits of its unique…
Helperby Therapeutics presented data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) announcing…
Lupin’s steady stride on biosims
Lupin’s biosimilar plans are reaching a crucial inflexion point, with recent positive global Phase III results of its etanercept…
Berry pigments can open new avenues for cancer treatment
The pigments can regulate a key enzyme in cancer cells
Lesaffre Human Care launches scientific papers on women’s health
Promising anti-fungal and anti-inflammatory properties for vaginal candidiasis therapy
Failure of the antimicrobials: A crisis at the door-step
MK Chattopadhyay, Retired Senior Principal Scientist, Centre for Cellular and Molecular Biology (CSIR), talks about the urgent…
YLB’s phase III clinical trial of Etanercept biosimilar meets positive outcome
The study was a multinational randomised double-blind controlled trial of 52 weeks duration which included more than 500 patients…
Cancer targeted with reusable ‘stinging nettle’ treatment
Cancer cells are killed more effectively and selectively with a new approach, using a substance found in stinging nettles and…